Co-authored Article
Novel Tumor Immunotherapy: Targeting Dysfunctional Antigen Presenting Cells
Abstract: T and B lymphocytes are high-profile fighters in the battlefields of immune responses. Antigen-presenting cells take in and process invading elements and tell T and B cells how to respond. These cells are found, however, to be betraying the body and actually helping tumor cells by inducing immunosuppression and tumor angiogenesis. Disabling or killing them becomes a novel therapeutic strategy in cancer therapy. ... Read more
